How to Participate
1.
Register to participate.
Participants can register through mid-January (although registration will be closed earlier if participant reaches the max capacity).
2.
Pre-pay Azenta Life Sciences for antibody production.
Azenta Life Sciences will produce the antibodies using the sequences provided at a reduced fee of $120 per antibody.
(You must be affiliated with an institution to create an account with Azenta).
3.
Complete the challenge(s).
Datasets for each challenge will be distributed on January 23, with participants having a period of 14 days to upload their sequence data.
Frequently Asked Questions.
Who can participate?
The competition is open to any individuals/groups/entities that want to help further antibody science.
Complete this form to register.
When does it start?
Participants can register beginning November 4 through mid-January. Registration may end sooner, as participation is capped at 1200 entries. Datasets for each challenge will be distributed on January 23, with participants having 14 days to provide their sequence data.
Why a competition?
AI is certainly a disruptive innovation in many areas of life sciences. The role of AI in antibody discovery is widely touted but has yet to be proven. By collating key antibody scientists and informaticists, we aim to better understand the landscape and help expedite the development and evolution of applied AI.
Additional Questions
The AIntibody program is administered by Specifica, an IQVIA business.
View the Terms of Participation
Email any questions to AIntibody@iqvia.com
Full Details
01
Applicants can participate in any (or all) of the challenges.
Participants can register through mid-January (although registration will be closed earlier if participant reaches the max capacity).
Datasets for each challenge will be distributed on January 23, with participants having a period of 14 days to upload their sequence data.
02
Azenta Life Sciences will produce the antibodies using the sequences provided. Once you have registered to participate, you will receive a confirmation email with a unique ID. The next step is create an account with Azenta’s GENEWIZ to pre-pay for your submissions (at a reduced fee of $120 per antibody). Please note that Azenta requires that you include an institution name when you register. This is part of their institution verification and compliance process.
- Be sure to include an institution name when you create your account.
- After logging into your account, please complete the profile as follows:
- Hover your mouse over your name in the upper right to reveal the drop-down menu
- Click on “Profile” and complete required, red asterisked fields.
- Click “Update form” at the bottom and you’re ready to go.
Step 2: Create and Save a Draft Order
- After creating your account, log in to GENEWIZ.
- Under the ‘Place an Order’ tab, choose Gene Synthesis.
- Choose Recombinant Antibody Production – Gene to Antibody.
- For ‘order name,’ use the unique ID that you received by email when you registered at AIntibody.org.
- For ‘promotion code,’ enter AIntibody.
- For BOTH ‘# of sequences’ and ‘# of antibodies’ enter a value of 1 and click the green ‘apply’ button for each.
- Click ‘save as draft.’
- At the bottom of the main page, under the ‘my orders’ tab, you should see your draft order.
- Using your unique AIntibody ID and the promotional code will notify the team at Azenta.
- The Azenta team will create a quote for your planned submissions.
Step 3: Confirm the Quote & Provide Payment
- Once you receive email notification of your quote, please log in to you GENEWIZ account.
- The draft order you created will now show “review quote” under the ‘Action’ tab.
- Review your quote and click “add to cart.”
- Add your payment information and click “check out” to complete payment for the synthesis and expression.
You can also review the PDF instructions for confirming a quote and providing payment.
03
Data sets for the challenge(s) will be sent by email on January 23. Upload your sequences by February 6.
04
Carterra will evaluate all submission for antibody affinities by surface plasmon resonance (SPR), and Sapidyne will test the highest affinity antibodies by KinExA.
Mosaic Biosciences will assess the developability (HIC HPLC, BVP ELISA, AC-SINS, DLS, Tm and Tagg).
05
Each participant will receive their individual assessment. Participants will be invited to be co-authors on published results papers.